Clinical Trial 46526

Brooklyn, NY 11235


Double-Blind, Placebo-Controlled, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of IONIS-AGT-LRX, an Antisense Inhibitor of Angiotensinogen Production Administered Subcutaneously for 12 Weeks to Hypertensive Patients with Uncontrolled Blood Pressure

Qualified Participants May Receive:

 If you qualify, you will get compensated up to $2500 for your participation. The study includes 19 home visits, and 1 home visit for a total of 20 visits. You will get compensated $125 for each visit you complete.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.